Real-time enrollment status for this opioid-induced esophageal dysfunction clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:21 PM UTC
| NCT Number | NCT05854303 |
| Recruiting Status | Recruiting |
| Condition | Opioid-Induced Esophageal Dysfunction |
| Phase | Clinical Trial |
| Target Enrollment | 26 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | October 16, 2025 (Oct 16, 2025) |
As of July 13, 2026: Clinical trial NCT05854303 is currently recruiting participants. This clinical trial study for opioid-induced esophageal dysfunction is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05854303 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05854303 was last updated Oct 16, 2025 (October 16, 2025). HelloStudys verifies this status automatically.